Key facts
- Notable investors include Tech Incubator Program for Startup, C&Venture Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Nbiocell
- ·The full record, as it builds
Funding rounds
No funding rounds for Nbiocell are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nbiocell
Developer of a nanocarrier platform designed to enhance the delivery of cosmeceutical, inner beauty, and health functional food products. The company offers advanced nanocarrier manufacturing, and a focus on beauty and health applications, enabling consumers to experience improved product efficacy, enabling enhanced absorption and targeted delivery of health and beauty ingredients.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Siheung, South Korea
- Founded
- 2021
- Website
- nbiocell.co.kr/
- Ownership
- Privately Held (backing)
Nbiocell doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nbiocell shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nbiocell in its N-PORT filings yet. We sweep new filings monthly.